🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Distaarikii Koloombiyaa › Washington

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Washington, DC keessatti

Qorannoo 24 Leukemia Myeloidii Hamaa f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06904066

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • Center for Cancer and Blood Disorders, Bethesda · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06852222

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

Longitudinal Studies of Patient With FPDMM

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
1 Day – 100 Years · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT03854318

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 12 hanga 120 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05436418

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Namoota walitti qabaa jiraQorannoo ilaalaa
  • The Center for Cancer and Blood Disorders, Bethesda · Miili 7 fagaatti
Umuriin 0 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07154823

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • Children's National - Main Hospital, Washington D.C.
29 Days – 21 Years · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05183035

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Namoota walitti qabaa jiraSadarkaa 1
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 3 hanga 35 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT02390752

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Childrens National Medical Center, Washington D.C.
6 Months – 80 Years · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT02203903

Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
1 Day – 120 Years · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT05350748

Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT05588154

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Children's National Medical Center, Washington D.C.
  • Nih/Niaid, Bethesda · Miili 7 fagaatti
  • Nih/Nhlbi, Bethesda · Miili 7 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

Namoota walitti qabaa jiraQorannoo ilaalaa
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
1 Month – 120 Years · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT07019155

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Center for Cancer and Blood Disorders (CCBD), Bethesda · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT04068597

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Cancer Support Community Research & Training Institute, Washington D.C.
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT02333604

Massage Impact on Sleep in Pediatric Oncology

Namoota walitti qabaa jira
  • Children's National Hospital, Washington D.C.
Umuriin 12 hanga 21 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06892158

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

Namoota walitti qabaa jiraSadarkaa 1/2
  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT04990102

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Washington keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.